View
942
Download
1
Category
Preview:
DESCRIPTION
European School of Management and Technology (ESMT), Guide for the master class with Dr. Marijn Dekkers, Chairman of the Board of Management of Bayer AG
Citation preview
Dr. Marijn Dekkers Chairman of the Board of Management of Bayer AG
Berlin, 25 August 2010
ESMT MasterClass Series 2010
Bottom alignment of Source and
Notes
Frame (not to be filled)
Agenda
Dr. Marijn Dekkers’ career path
Bayer in a nutshell
Introduction to the full-time MBA 2010 Class
Questions: Leadership, Career development and Post-Merger Integrations
Bottom alignment of Source and
Notes
Frame (not to be filled)
3
Dr. Marijn Dekkers’ career path
Source: businessweek.com, bayer.de
Born: 1957, TilBurg, NL
Nationality: Dutch/USA
Education: PhD -University Eindhoven, BSC in Chemical Engineering - University of Nijmegen
Bottom alignment of Source and
Notes
Frame (not to be filled)
4
Bayer - Science For A Better Life: Credo and values
Source: www.bayer.de
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.
As an inventor company, we set trends in research-intensive areas. Our products and services are designed to benefit people and improve their quality of life.
At the same time we aim to create value through innovation, growth and high earning power.
We are committed to the principles of sustainable development and to our social and ethical responsibilities as a corporate citizen.
Bottom alignment of Source and
Notes
Frame (not to be filled)
5
The strategic management is responsible for sustainably increasing the company’s enterprise value and achieving defined corporate objectives
HQ in Leverkusen, Germany
Board of Mgmt directs the Group’s operations Supervisory Board oversees and advises BM.
Source: Bayer Annual Report 2009 - as of March 2010
Bottom alignment of Source and
Notes
Frame (not to be filled)
6
The Bayer Group is a global enterprise with over 290 companies worldwide
Source: Bayer Annual Report 2009
Business Strategy:
HealthCare: Expansion of product range, entering new strategic partnerships
CropScience: Development of new products to replace older technologies
MaterialScience: Safeguarding existing competitive position, achieving profitable growth in the EM
Overarching strategy: Expansion in the Emerging Markets, particularly in Asia
Bottom alignment of Source and
Notes
Frame (not to be filled)
Industry sector
ESMT’s MBA Class of 2010 is represented by professionals with a strong technological background and managerial experience.
Educational background
One year program: 39 Students, 21 Nationalities, 26 languages
35% female, average working experience: 6 years
5Source: ESMT web site
Bottom alignment of Source and
Notes
Frame (not to be filled)
Questions: On Leadership and Decisions
8
1. During the last year several leadership changes took place in Bayer AG. What is the strategy the company pursues in making those changes? What challenges do transition periods during replacement of the management pose?
2. What do you think is fair compensation for top management? What are the key factors to identify correct award and bonus systems for them?
3. What is Bayer CropScience’s strategy in GM technology? How do you deal with trade-offs between short-term profits and ethical issues such as CSR and sustainability?
Bottom alignment of Source and
Notes
Frame (not to be filled)
9
Questions: Talent & Career Development
1. As an executive who worked for US-based companies, you gained substantial experience in the “American way” of doing business. Which successful experiences or approaches can be transferred to Bayer in Germany and worldwide?
2. Almost half of our classmates are professionals with engineering experience. What is your advice for those students who are pursuing business career?
3. In your opinion, which set of skills is essential for a leader? Is there any of those which is particularly required for your industry?
Bottom alignment of Source and
Notes
Frame (not to be filled)
Questions: Post-Merger Integrations
10
In 2006, under your leadership, Thermo Electron Corp. successfully acquired a significantly larger company, Fisher Scientific. Keeping this context in mind:
1. Did you face contradictions between the vision and the values expressed by the two companies before the merger? If so, how did you deal with those issues?
2. How did you identify key people in the post-merger organization and motivate them to work in the new environment?
3. The acquisition of Schering in 2006 was the largest transaction in Bayer’s history and promised to leverage profit from synergies, especially in R&D. Has that merger delivered on its potential promise?
Bottom alignment of Source and
Notes
Frame (not to be filled)
11
Moderators
Sandro Jordao
MBA Candidatesandro.jordao@mba2010.esmt.org
Yelena Omelchenko
MBA Candidateolena.omelchenko@mba2010.esmt.org
ESMTEuropean School of Management and Technology
Schlossplatz 110178 Berlin
www.esmt.org
Recommended